Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine-Reference-Cited by-同舟云学术

Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine

Published:2012-01 Issue:1 Volume:20 Page:91-100
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Polach Kevin J,Matar Majed,Rice Jennifer,Slobodkin Gregory,Sparks Jeff,Congo Richard,Rea-Ramsey Angela,McClure Diane,Brunhoeber Elaine,Krampert Monika,Schuster Andrea,Jahn-Hofmann Kerstin,John Matthias,Vornlocher Hans-Peter,Fewell Jason G,Anwer Khursheed,Geick Anke

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. RNAi-based therapeutics-current status, challenges and prospects;Tiemann;EMBO Mol Med,2009

2. Small silencing RNAs: state-of-the-art;Grimm;Adv Drug Deliv Rev,2009

3. A status report on RNAi therapeutics;Vaishnaw;Silence,2010

4. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs;Soutschek;Nature,2004

5. Nonviral delivery of synthetic siRNAs in vivo;Akhtar;J Clin Invest,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Patent Analysis on Nano Drug Delivery Systems;Recent Patents on Nanotechnology;2024-07-09

2. The Promising Therapeutic Potential of Oligonucleotides for Pulmonary Fibrotic Diseases;Expert Opinion on Drug Discovery;2022-12-26

3. Dendrimer–siRNA Conjugates for Targeted Intracellular Delivery in Glioblastoma Animal Models;ACS Applied Materials & Interfaces;2022-10-10

4. Tumor-targeted nano-delivery system of therapeutic RNA;Materials Horizons;2022

5. Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment;Advanced Healthcare Materials;2021-05-11